• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    SYSTEMS AND METHODS FOR PROVIDING A CATHETER ASSEMBLY The present invention is intended for a system for controlling the flow of fluid in a catheter assembly (101) which is disclosed in the present. An intravenous catheter assembly has a catheter adapter (14) and a needle connector, and the catheter adapter has an internal lumen. A septum (50) is arranged in a part of the internal lumen and a slit (56) is formed through the septum. A Parilene coating is placed in the septum slit, with the Parilene coating having a thickness between approximately 0.00005 and 0.0005 mm. An introducer needle has a first end attached to the needle connector and the second end extending through the internal lumen of the catheter adapter. An intermediate part of the introducing needle is positioned in a part of the septum.
    公开号:BR112013022947B1
    申请号:R112013022947-0
    申请日:2012-02-14
    公开日:2021-02-17
    发明作者:Marty L. Stout；Weston F. Harding；S. Ray Isaacson；Austin Jason Micknnon
    申请人:Becton, Dickinson And Company；
    IPC主号:
    专利说明:

    [0001] [001] The current invention relates to infusion devices, specifically to peripheral intravenous (IV) catheters. In particular, the invention relates to a peripheral flushable IV catheter assembly equipped with features to enable the selective activation of fluid flow through the catheter assembly.
    [0002] [002] Catheters are commonly used for a variety of infusion therapies. For example, catheters are used to infuse fluids, such as normal saline, various medications, and total parental nutrition into a patient, to draw blood from a patient, as well as to monitor various parameters of the patient's vascular system.
    [0003] [003] The catheters or needles are typically coupled to a catheter adapter to enable the attachment of IV tubing to the catheter. Thus, the next placement of the catheter or needle in a patient's vasculature, the catheter adapter is coupled to a fluid source via an IV tubing section. In order to verify the proper placement of the needle and / or catheter in the blood vessel, the clinician usually confirms that there is "return" of blood in a return chamber of the catheter assembly.
    [0004] [004] Once the proper placement of the catheter is confirmed, the clinician must then attach the catheter adapter to a section of the IV tubing. This process requires the clinician to manually occlude the vein to prevent unwanted exposure to blood. Manual occlusion of the patient's vein requires the clinician to awkwardly maintain pressure on the patient's vein while simultaneously coupling the catheter adapter and IV tubing.
    [0005] [005] A common, though undesirable, practice is to allow blood to flow temporarily and freely from the catheter adapter while the clinician locates and couples the IV tubing to the catheter adapter. Another common practice is to attach the catheter adapter to the IV tubing before placing the needle or catheter in the patient's vein. Although this method can prevent unwanted exposure to blood, positive pressure in the IV duct can also prevent the desirable return.
    [0006] [006] Complications associated with infusion therapy include significant morbidity and even mortality. Such complications can be caused by regions of stagnant fluid flow in the vascular access device or areas close to the extravascular system. There are regions where fluid flow is limited or non-existent due to the conformation of the septum or valve mechanism in the extravascular system or due to the dynamics of the fluid in this area of the extravascular system. Blood, air bubbles, or infused medications can become trapped in these regions of stagnant flow as a result of limited or nonexistent fluid flow. When blood is trapped in the extravascular system, bacteria can breed, which can lead to infections. When a different medication is infused into the extravascular system, or the extravascular system is exposed to physical trauma, the fluid flow from the extravascular system can be changed, releasing air bubbles or residual medications trapped back into the active fluid path of the system extravascular. This release of air bubbles and residual medication in the extravascular system of the active fluid pathway can result in significant complications.
    [0007] [007] The released air bubbles can block the flow of fluid through the extravascular system and prevent its proper functioning. More seriously, released air bubbles can enter the patient's vascular system and block blood flow, causing tissue damage and even stroke. In addition, residual medications can interact with medications presently infused to cause precipitates in the extravascular system and prevent their proper functioning. In addition, residual medications can enter the patient's vascular system and cause unintended and / or unwanted effects.
    [0008] [008] Thus, there is a need in the art for a catheter assembly that allows a desirable and controlled return without the risk of encountering undesirable exposure to blood. In addition, there is a need in the art to provide a valve mechanism in a catheter assembly that eliminates, prevents, or limits regions of stagnant flow in vascular access devices and in the extravascular system to provide better jet properties. Such a catheter assembly is disclosed at present. summary
    [0009] [009] In order to overcome the limitations discussed above, the present invention relates to a peripheral flushable IV catheter assembly equipped with features to enable the selective activation of fluid flow through the catheter assembly. The catheter assembly of the present invention generally includes a catheter attached to a catheter adapter. The catheter generally includes a metallic material, such as titanium, surgical steel or an alloy as is commonly known in the art. In some embodiments, a polymeric catheter can be used in combination with a metallic introducer needle, as is commonly known and used in the art.
    [0010] [010] In some embodiments of the present invention, a septum is positioned in a lumen of the catheter assembly to prevent or limit the flow of a fluid through the catheter adapter. The septum usually includes a flexible or semi-flexible material that is compatible with exposure to blood, medications and other fluids commonly found during infusion procedures. In some embodiments, a groove is provided on an internal surface of the catheter adapter, where the septum is seated in the groove. As such, the position of the septum on the catheter adapter is maintained.
    [0011] [011] In some implementations of the present invention, a closed or partially closed aisle, such as a crack or small hole, is additionally provided on a surface of the septum barrier. The aisle allows fluid to bypass the septum and flow through the catheter adapter. In some embodiments, the aisle is a slit that is closed before being opened or activated by a probe or septum activator positioned in the lumen of the catheter adapter. Before opening or activating, the slit prevents fluid from passing through the catheter adapter. Thus, in some embodiments, a plurality of channels for air ventilation are interposed between the septum and the groove to allow air to flow through the catheter adapter before the slit is opened. Air vents prevent the accumulation of positive pressure in the catheter adapter, thereby allowing blood to return to the catheter and a front chamber of the catheter adapter.
    [0012] [012] The septum activator usually includes a plastic or metallic tubular body with a probing tip and a contact tip. The probing end is positioned adjacent to the septum corridor, and the contact end is positioned adjacent to a proximal inlet of the catheter adapter. The probing end of the septum activator is advanced through the septum corridor when a probe is inserted into the proximal inlet of the catheter adapter. As the probe makes contact with the contact surface of the septum activator, the septum activator is advanced in a distal direction through the catheter adapter where the probing end of the septum activator opens the aisle through the septum. Once opened, the flow of free fluid is made possible through the assembly of the catheter.
    [0013] [013] In some respects, a Parilene coating is placed on the surface of the septum, included in the surfaces of the septum cleft. The thickness of the liner is between 0.00005 to 0.0005 mm in order to allow the septum to open and close properly. In some embodiments, the thickness of the coating is between 0.0001 to 0.0002 mm. The septum can comprise a silicone rubber material and has a configuration with three slits (three slits that are at a central point to form a single entrance).
    [0014] [014] Finally, the presence of the septum activator in the lumen of the catheter adapter can result in abnormal fluid flow that leads to undesirable stagnation and fluid clotting in the catheter assembly. Thus, in some embodiments of the present invention, the septum activator additionally includes several flow deflectors and / or flow diversion channels to maintain the appropriate fluid flow in the catheter adapter. Brief description of the different views of the drawings
    [0015] [015] In order that the manner in which the features and advantages of the above-described invention and others are obtained are readily understood, a more particular description of the invention briefly described above will be carried out by reference to its specific modalities, which are illustrated in the attached drawings. These drawings depict only the typical modalities of the invention and should therefore not be considered as limits to the scope of the invention.
    [0016] [016] Figure 1 is a cross-sectional view of a permanent catheter equipped with a flow control valve mechanism from the PREVIOUS TECHNIQUE.
    [0017] [017] Figure 2 is a cross-sectional view of the permanent catheter of the PREVIOUS TECHNIQUE of Figure 1 that follows the removal of an introducing needle.
    [0018] [018] Figure 3 is a cross-sectional view of the permanent catheter of the PREVIOUS TECHNIQUE of Figures 1 and 2 following the insertion of a cube from a vascular access device.
    [0019] [019] Figure 4 is a perspective view of an embodiment of a catheter assembly in accordance with the present invention.
    [0020] [020] Figure 5A is an exploded cross-sectional view of a catheter assembly according to the present invention.
    [0021] [021] Figure 5B is a perspective view of an embodiment of a septum according to the present invention.
    [0022] [022] Figure 6A is a cross-sectional view of an inner lumen of a catheter adapter that demonstrates fluid flow without the presence of a septum activator according to a representative embodiment of the present invention.
    [0023] [023] Figure 6B is a perspective view of an embodiment of a septum activator according to the present invention.
    [0024] [024] Figure 6C is a side view of an embodiment of a septum activator arranged in an internal lumen of a catheter adapter according to the present invention, which follows activation.
    [0025] [025] Figure 6D is a side view of an embodiment of a septum activator disposed in an internal lumen of a catheter adapter according to the present invention, which demonstrates the flow of fluid through the catheter adapter.
    [0026] [026] Figure 7 is a cross-sectional view of a catheter assembly assembled in accordance with the present invention, prior to activation.
    [0027] [027] Figure 8 is a cross-sectional view of a catheter assembly assembled in accordance with the present invention, which follows activation.
    [0028] [028] Figure 9 is a cross-sectional view of a catheter assembly on the needle assembled in accordance with the present invention, prior to activation.
    [0029] [029] Figure 10 is a cross-sectional view of a catheter assembly on the needle assembled according to a representative embodiment of the present invention, following the removal of the introducing needle.
    [0030] [030] Figures 11A through 11D are seen in cross section of the septum which has several characteristics and the configuration according to the representative modalities of the present invention.
    [0031] [031] Figure 12 is a cross-sectional view of a catheter assembly on the needle assembled according to a representative embodiment of the present invention, which follows activation.
    [0032] [032] Figure 13 is a cross-sectional view of a catheter body equipped with a flow control valve mechanism and a septum activator according to a representative embodiment of the present invention, before activation.
    [0033] [033] Figure 14 is a cross-sectional view of a catheter body provided with a flow control valve mechanism and a septum activator according to a representative embodiment of the present invention, which follows activation.
    [0034] [034] Figure 15 is a cross-sectional view of a catheter body provided with a flow control valve mechanism and a septum activator according to a representative embodiment of the present invention, before activation.
    [0035] [035] Figure 16 is a cross-sectional view of a catheter body equipped with a flow control valve mechanism according to a representative embodiment shown in Figure 15, which follows activation.
    [0036] [036] Figure 17 is a cross-sectional view of a catheter body provided with a flow control valve mechanism and a septum activator according to a representative embodiment of the present invention, before activation.
    [0037] [037] Figure 18 is a cross-sectional view of a catheter body equipped with a flow control valve mechanism according to a representative modality shown in Figure 17, which follows activation.
    [0038] [038] Figure 19 is a cross-sectional view of a catheter body provided with a flow control valve mechanism and a septum activator according to a representative embodiment of the present invention, before activation.
    [0039] [039] Figure 20 is a cross-sectional view of a catheter body equipped with a flow control valve mechanism according to a representative modality shown in Figure 19, which follows activation. Detailed description of the invention
    [0040] [040] The presently preferred embodiment of the present invention will be better understood by reference to the drawings, in which the same numerical references indicate identical or functionally similar elements. It will be readily understood that the components of the present invention, as generally described and illustrated in the Figures at present, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description, as represented in the Figures, is not intended to limit the scope of the invention as claimed, but is merely representative of the presently preferred embodiments of the invention.
    [0041] [041] The term “proximal” is used to denote a part of a device that, during normal use, is the closest to the user and the furthest from the patient. The term "distal" is used to denote a part of a device that, during normal use, is the furthest from the user handling the device and the closest to the patient. The term "activation" of the valve or septum mechanism is used to denote the action of entering or closing such a valve.
    [0042] [042] An example of an extravascular system of the prior art is disclosed in US Patent 7,008,404 and shown in Figures 1 to 3. A permanent catheter has, as shown in Figure 1, a hollow catheter body 1, an embedded catheter 2 in a retainer 1b provided at a distal end of the catheter body 1, a septum 3 fitted within the body of catheter 1 and a hollow pusher 4 slidably fitted within the body of catheter 1. The catheter tube 2, the septum 3 and the pusher 4 are coaxially aligned in this order.
    [0043] [043] The body of catheter 1 has a tubular shape. An inner surface 1a is tapered towards the distal end, with a gradually reduced diameter. The body of the catheter 1 is preferably made of a transparent or semi-transparent material to show the inside, making it possible to check the movement on the inside. Suitable materials for the body of catheter 1 include, but are not limited to, thermoplastic polymeric resins such as polycarbonate, polystyrene, polypropylene and the like.
    [0044] [044] The catheter 2 is pressed into the tube retainer 1b, which communicates at its proximal end with the inside of the body of catheter 1. It is preferred that a lubricant coating is provided for all or part of catheter 2 in order to reduce the resistance caused by insertion through the skin or into a blood vessel. Such catheter 2 materials include, but are not limited to, thermoplastic resins such as fluorinated ethylene propylene (FEP), polytetrafluoroethylene (PTFE), polyurethane and the like. Preferably, catheter 2 is formed of a thermoplastic hydrophilic polyurethane which softens upon exposure to the physiological conditions present in the patient's body.
    [0045] [045] The septum 3 is generally tubular in shape with a proximal end 8 and a membrane section 9 provided with a flat planar surface 10 located at the distal end 11. Typically, septum 3 additionally includes a single needle slot 3a or valve opening located near the center of the membrane section 9, extending through the membrane section 9, to facilitate the penetration of the septum 3 by the introducer needle 5. The opposite slit surfaces of the needle slot 3a are designed to meet approximate the shape of the introducer needle 5 during storage and prevent an outflow of fluid during and after the removal of the introducer needle 5, then to seal in the removal of the introducer needle 5. With the pusher 4 inserted through from it, slot 3a expands forward in the distal direction and opens, providing fluid communication between catheter 2 and the rear of catheter 1 body. An annular protuberance 3b is strong provided on the inner surface of a rear entrance of the septum 3, to engage the shoulder 4c at the distal end of the pusher 4 in order to limit the movement of the pusher 4 in the proximal direction and to prevent the movement of the pusher 4 from the septum 3. A plurality of gaps 3c is defined between an outer periphery of the septum 3 and the inner surface 1a of the body of catheter 1. The distal and proximal spaces divided by the septum 3 communicate with each other through the gaps 3c. Thus, the septum 3 glides smoothly with the air that passes through the gaps 3c.
    [0046] [046] Pusher 4 is typically made of a rigid thermoplastic material or a similar material and has a lumen that extends through it. The pusher 4 has a tubular part 4a, a conical flange 4b connected to the rear proximal end of the tubular part 4a, and a shoulder 4c protruding from an outer periphery of the tubular part 4a. Thus, an interstitial space with annular shape is created between the tubular part 4a and the inner surface 1a of the body of catheter 1. The distal front end of the tubular part 4a is chamfered to facilitate its penetration into the slit 3a of the septum 3, and is slidably supported by the annular protuberance 3b of the septum 3. The tapered flange 4b has a tapered internal surface in order to facilitate the insertion of the needle 5 into it. The peripheral surface of the flange 4b makes contact with the inner surface 1a of the body of the catheter 1 and serves to provide stability to the pusher 4 and to maintain the coaxial position with respect to the catheter 2. However, the peripheral surface of the flange 4b does not form a fluid seal with inner surface 1a.
    [0047] [047] The permanent catheter is prepared for use in such a state as shown in Figure 1 with the front end of needle 5 protruding from the front end of catheter 2. In this state, needle 5 penetrates through septum 3, providing the connection waterproof between them, and thereby preventing blood leakage.
    [0048] [048] The permanent catheter, in this state, is inserted into a patient's body. Then, as shown in Figure 2, needle 5 is removed with tube 2 retained in the patient's body. The septum 3 maintains a fluid seal when removing the needle 5, which is retained in the body of the catheter 1 by an annular protuberance 1e. The pusher 4 is held in a proximal position by the interaction of the annular protuberance 3b and the shoulder 4c.
    [0049] [049] A cube 6 (for example, luer cube) of a vascular access device is then inserted from the proximal end of the body of catheter 1. When pressed into the body of catheter 1, cube 6 pushes, in its the distal end, the pusher 4. The pusher 4 then slides forward in the distal direction to press, at its distal end, the gap 3a of the septum 3 open, thereby activating the flow control valve to the open position. The septum 3 is then pressed against the inner surface of a tapered cavity 1c of the body of the catheter 1 which stops the forward movement of the pusher 4 in a distal position as shown in Figure 3, thus providing communication between the catheter 2 and the vascular access device. The tapered inner surface 1a of the body of the catheter 1 allows smooth insertion of the hub 6 and tight contact between an outer surface 6a of the hub 6 and the inner surface 1a through the pressure fitting to prevent fluid from draining from the proximal end of the catheter body 1.
    [0050] [050] However, it should be noted that this valve mechanism has small spaces / interstitial areas in the catheter body 1 into which fluids can flow during use, which gives rise to areas of low or no flow fluid flow. For example, in use, fluid can flow between the peripheral surface of the flange 4b and the inner surface 1a of the catheter body 1 and into the interstitial space 98 between the outer periphery of the tubular part 4a and the inner surface 1a. In addition, the fluid can flow into the interstitial space 99 which is the gap 3c between the outer periphery of the septum 3 and the inner surface 1a of the catheter body 1. The low fluid flow or the lack of flow that exists in the spaces / areas 98 and 99 subsequently make it very difficult to spill any blood, medication or air bubbles that may flow into these areas during the use of the catheter.
    [0051] [051] Referring now to Figure 4, a catheter assembly 101 is illustrated. Catheter assembly 101 generally includes a catheter 12 coupled to a distal end 32 of a catheter adapter 14. The catheter 12 and the catheter adapter 14 are integrally coupled such that an internal lumen 16 of catheter adapter 14 is in fluid communication with a lumen 18 of catheter 12. Catheter 12 generally comprises a biocompatible material provided with sufficient rigidity to withstand pressures associated with insertion of the catheter. catheter in a patient. In some embodiments, catheter 12 comprises a metallic material, such as titanium, stainless steel, nickel, molybdenum, surgical steel and their alloys. In other embodiments, catheter 12 comprises a rigid polymer material, such as vinyl. A portion of the catheter tip 20 is generally configured to include a chamfered cutting surface 48. The chamfered cutting surface 48 is used to provide an entrance to a patient to allow insertion of catheter 12 into the patient's vascular system.
    [0052] [052] The characteristics of the catheter assembly can be incorporated for use with a catheter assembly on the needle. For example, a flexible or semi-flexible polymer catheter can be used in combination with a rigid introducer needle to make it possible to insert the catheter into a patient. Catheters surgically implanted can also be used.
    [0053] [053] Once inserted into a patient, catheter 12 and catheter adapter 14 provide a fluid conduit to facilitate the release of a fluid and / or the recovery of a fluid from a patient, as required by an infusion procedure wanted. Thus, in some modalities, catheter material 12 and catheter adapter 14 are selected to be compatible with biofluids and drugs commonly used in infusion procedures. Additionally, in some embodiments, a portion of catheter 12 and / or catheter adapter 14 is configured for use in conjunction with a section of intravenous tubing 40 to further facilitate the release of a fluid or the removal of a fluid from a patient.
    [0054] [054] In some embodiments, a proximal end 22 of the catheter adapter 14 includes a flange 28. The flange 28 provides a positive surface that can be configured to allow the attachment of an intravenous tubing or patient conduit 40 to the catheter assembly 101 In some embodiments, the flange 28 includes a set of threads 30. The threads 30 are generally provided and configured to receive, in a compatible manner, a complementary set of threads 44 comprising a part of a male luer or conduit coupler 42. The conduit coupler 42 is generally coupled to an end portion of the patient conduit 40 in a fluid-proof manner. In some embodiments, an inner portion of the conduit coupler 42 is extended outwardly to provide a surface of probe 46.
    [0055] [055] The surface of probe 46 is generally configured to insert, in a compatible manner, at a proximal end 22 of catheter adapter 14. Following the insertion of probe 46 at proximal end 22 of catheter adapter 14, conduit coupler 42 it is rotated to interlock the coupler 42 and the flange 28 (by means of sets of threads 30 and 44). During the process of interlocking coupler 42 and flange 28, probe 46 is advanced into lumen 16 of catheter adapter 14 to an inserted position (as shown in Figure 8). The inserted position of the probe surface 46 activates catheter assembly 101 to allow fluid flow through catheter 12 and catheter adapter 14. Once conduit coupler 42 and catheter adapter 14 are attached, a fluid it can be released to a patient via patient conduit 40 and catheter 12 inserted.
    [0056] [056] Referring now to Figure 5A, an exploded cross-sectional view of a catheter assembly 101 is shown. In some embodiments, catheter adapter 14 includes various design features and components to control and / or limit the flow of fluid through the catheter assembly 101. For example, in some embodiments of the present invention, a septum 50 is positioned in the inner lumen 16 of the catheter adapter 14. The septum 50 generally comprises a flexible or semi-flexible polymer plug provided of an external diameter that is configured to fit, in a compatible manner, in a groove or channel 60 formed on an internal surface 24 of the catheter adapter 14. In some embodiments, the septum 50 has the shape of a barrel provided with a surface of the barrier 52 comprising a distal end of the septum 50 and additionally provided with an inlet 54 comprising a proximal end of the septum 50. When positioned in channel 60, the surface of the bar sept 52 52 of the septum 50 divides the inner lumen 16 of the catheter adapter 14 into a front fluid chamber 62 and a rear fluid chamber 64. Thus, the presence of septum 50 controls or limits the passage of fluid between the front fluid chambers and rear 62 and 64. Specifically, a chosen configuration of the barrier surface 52 of the septum 50 largely determines the ability of a fluid to flow through the inner lumen 16 of the catheter adapter 14.
    [0057] [057] For example, in some embodiments, the barrier surface 52 of the septum 50 is configured to include a slit 56. Slit 56 is configured to provide access or selective flow of a fluid through the surface of the barrier 52. In some modalities, the slot 56 is configured to remain in a closed fluid-proof position until it is activated or opened by advancing a septum activator 80 through the slot 56 in a distal direction 390. In some embodiments, the surface of the barrier 52 comprises a slit 56. In other embodiments, the surface of the barrier 52 is modified to include several slits 56 and 66, as shown in Figure 8. For example, septum 50 can include a three-slit configuration, where the three slits meet at a central point to form a single entry. In some embodiments, the septum 50 comprises a silicone rubber material. In some embodiments, the septum 50 essentially consists of a silicone rubber material.
    [0058] [058] In some respects, a Parilene coating is disposed on the surface of the septum 50, included in the surfaces of the slit 56 of the septum 50. Parilene is a chemically resistant coating with good barrier properties for inorganic and organic fluids, strong acids, caustic solutions, gases and water vapors. In some embodiments, a Parilene coating is applied to the outer surface of the septum 50 by means of vapor deposition. A Parilene coating is a harder material than the material of the septum substrate, such as silicon rubber or a similar material. When the septum 50 is coated with the typical thickness of the industrial Parilene, which is greater than 1 micrometer, the edges of the gap 50 become very rigid. The typical coating thickness for Parilene in the industry is in the range of 0.001 to over 0.025 millimeters. The harder edge of the slit blade could indent the soft face of the slit, thus preventing the slit from closing properly after withdrawing the needle. This increased resistance to closing makes the seal not so efficient. In addition, when the septum 50 is coated with an industrial-standard thick layer of Parilene, the coefficient of friction between the septum 50 and the inner surface 24 of the catheter adapter 14 is reduced, thereby reducing the force required to remove the septum 50 from inside the catheter adapter 14. On the other hand, when the septum is not coated with Parilene, the silicone septum is sticky and difficult to insert in the automated process.
    [0059] [059] Thus, in some configurations, the thickness of the coating can be between 0.00005 to 0.0005 mm. In other embodiments, the thickness of the coating is between 0.0001 to 0.0035 mm. In other embodiments, the thickness of the coating is between 0.0001 to 0.0002 mm. With this type of thin layer of Parilene coating, the slit 56 will close easily after the needle is removed. In addition, the reduced thickness of the Parilene lining will provide additional frictional force between the outer surface of the septum 50 and the inner surface 24 of the catheter adapter 14, increasing the holding force of the septum 50.
    [0060] [060] For some infusion therapy techniques, it may be desirable to allow a controlled flow of fluid through the septum 50 before activating the septum 50 with the septum activator 80. Thus, in some embodiments, the slot 56 additionally comprises an orifice Drain 58. Drain orifice 58 is positioned on the surface of the barrier 52 and comprises an inlet diameter calculated to allow controlled flow of liquid or air between the front and rear chambers 62 and 64. In some embodiments, the surface of the barrier 52 is modified to include a single flow hole 58. In other embodiments, the surface of barrier 52 is configured to include multiple flow holes. Yet, in other embodiments, the surface of the barrier 52 does not include a slot 56, but instead includes at least one drainage hole 58. For these embodiments, the septum 50 generally comprises an elastic material such that when the septum activator 80 is advanced in a distal direction 390, a leading edge 92 of the septum activator 80 makes contact with the surface of the barrier 52 and stretches the orifice 58 to provide a wider orifice, thereby allowing air flow and / or increased fluid through the catheter adapter 14.
    [0061] [061] The groove or channel 60 on which the septum is seated comprises a recessed portion of the inner surface 24 of the catheter adapter 14. The outer diameter of the septum 50 is generally configured to sit compatible and securely in channel 60. For example , in some embodiments, the outer diameter of the septum 50 is selected to be either slightly smaller than the diameter of the channel 60 or slightly larger than the diameter of the inner lumen 16. As such, the septum 50 is retained in the channel 60 during use of catheter assembly 101.
    [0062] [062] For some infusion therapy techniques, airflow between the front and rear chambers 62 and 64 may be desirable. For example, for those modalities that comprise a septum 50 provided with a fluid-proof slit 56, the passage of air from the front chamber 62 to the rear chamber 64 is prohibited before opening or activating the septum 50 by means of the septum activator. 80, as previously discussed. Thus, when catheter 12 of catheter assembly 101 is inserted into a patient's vascular system, positive pressure develops in the front chamber 62, thereby preventing the desired return of the patient's blood in catheter adapter 14. An observable return it is generally desirable to confirm the precise placement of the catheter tip 20 in the patient's vein. Thus, some embodiments of the present invention include features or elements to enable airflow between the front chamber 62 and the rear chamber 64, without requiring activation of the septum 50 with the septum activator 80. As such, some embodiments of the present invention provide observable feedback, as generally desired for infusion procedures.
    [0063] [063] For example, in some embodiments the surface of the barrier 52 of the septum 50 is modified to include the flow orifice 58, as previously discussed. In other embodiments, a plurality of channels for air ventilation 70 are interposed between the septum 50 and the inner surface 24 of the catheter adapter 14. The channels for air ventilation 70 relieve positive pressure in the front chamber 62 by providing an access to the air deviates from the septum 50 to the rear chamber 64. In some embodiments, the air ventilation channels 70 are constructed by removing parts of the surface of the channel 60, resulting in a plurality of generally parallel grooves.
    [0064] [064] In addition to allowing air flow between the front and rear chambers 62 and 64, ventilation channels 70 can be configured to allow fluid to flow through catheter adapter 14 before activating or opening slot 56 with the septum activator 80. In some embodiments, the rate at which air and / or fluid flows between the front and rear chambers 62 and 64 is adjusted when making catheter adapter 14 to include more or less ventilation channels 70. In other embodiments, the rate at which air and / or fluid flows between the front and rear chambers 62 and 64 is adjusted when fabricating catheter adapter 14 to include ventilation channels 70 provided with a larger cross-sectional area or less. Thus, in some embodiments, the rate at which air and / or fluid flows between the front and rear chambers 62 and 64 is increased when manufacturing a catheter adapter 14 provided or an increased number of channels for ventilation 70 or channels for ventilation 70 with a larger cross-sectional area. Conversely, in other embodiments, the rate at which air and / or fluid flows between the front and rear chambers 62 and 64 is decreased when manufacturing a catheter adapter 14 provided or a decreased number of ventilation channels 70 or channels for ventilation 70 with a smaller cross-sectional area.
    [0065] [065] With continued reference to Figure 5A, the septum activator 80 comprises a probe-like structure that is primarily housed in the rear chamber 64 of the catheter adapter 14. The septum activator 80 generally comprises a tubular body 82 provided with an end distal 84 and a proximal end 86. The tubular body 82 comprises a rigid or semi-rigid material, such as a plastic or metallic material. The tubular body 82 additionally comprises an internal lumen 88 to facilitate the flow of a fluid and / or liquid through the septum activator 80.
    [0066] [066] The distal end 84 of the tubular body 82 is configured to insert into the entrance 54 of the septum 50 in a compatible manner. The distal end 84 additionally includes a probing surface 90 that extends through the entrance 54 of the septum 50 to a position proximal to the surface. of septum barrier 52, as shown in Figure 8. The probing surface 90 is advanced through slots 56 and 66, or through drain hole 58 as the septum activator is advanced through catheter adapter 14 in a distal direction 390. The advancement of the septum activator 80 through the catheter adapter 14 will be discussed in detail below, in connection with Figures 7 and 8.
    [0067] [067] Still, in other embodiments, septum 50 is coated with a hydrophobic coating or a polymeric coating with expansion to repel or prevent fluid from flowing through the ventilation channels 70. A hydrophobic coating is generally selected to reduce the energy of the surface of the septum 50 and / or adapter 14 to inhibit blood capillarity in air vents 70. In some embodiments, a surface of the septum 50 or catheter adapter 14 is coated with a polyxylene polymer material, such as Parilene. In other embodiments, a polyxylene polymer coating is applied to a ventilation channel 70 by means of vapor deposition.
    [0068] [068] In some embodiments, a dehydrated polymer material is applied to a surface of the septum 50 or catheter adapter 14 comprising ventilation channels 70. A dehydrated polymer is generally selected to expand or swell upon contact with the fluid. As such, when the dehydrated polymer swells, a flow through the ventilation channels 70 is blocked or occluded by the swollen polymer. Initially, the dehydrated polymer generally comprises a thin profile for exposure to moisture. However, when exposed to moisture the polymer absorbs moisture which increases the profile of the polymer to block the flow through ventilation 70. Therefore, by coating the septum 50 and / or the catheter adapter 14 with a desired coating, the flow of air is allowed between the front and rear chambers 62 and 64, yet the flow of fluid through the ventilation channels 70 is prevented.
    [0069] [069] Referring now to Figure 5B, an embodiment of a septum 150 is shown. In some embodiments, an outer surface 166 of the septum 150 is modified to include a plurality of indented grooves 72. The indented grooves 72 provide corridors between the front and rear chambers 62 and 64 through which air and / or fluid can flow. Thus, in some embodiments, the channel 60 does not include channels for air ventilation 70, but instead, the outer surface 166 of the septum 150 is modified to provide the desired flow between the front and rear chambers 62 and 64.
    [0070] [070] The patient's blood pressure is hugely responsible for the rate at which blood and air flow through the septum 50 and 150 of the 101 catheter assembly. As such, the flow rate through the system is affected by the combined efficient hydraulic diameter of all flow paths. Thus, in some embodiments, the hydraulic diameter of the ventilation channels 70 and / or the recessed grooves 72 is modified to increase or decrease the flow rate through the assembly of catheter 101. In other embodiments, the hydraulic diameter of the ventilation channels 70 and / or the recessed grooves 72 is thereby decreased, resulting in substantially reduced or stopped flow through the ventilation means. The dominant equation for controlling the flow rate through the ventilation means is given in Equation 1, where BP is the blood pressure, A is the surface area of the ventilation means, ό is the blood surface tension and P is the perimeter of the ventilation means. Equation 1: BP (A) = ό (P)
    [0071] [071] Thus, according to Equation 1, when the perimeter of the ventilation means is small, the ventilation means will allow the air to ventilate, but will prevent blood flow due to the relatively high surface tension (ό) of the blood. However, when the perimeter of the ventilation means is increased, the surface tension between the blood and the ventilation is thereby decreased, allowing the blood to flow slowly through the ventilations and around the septum to provide the desired return and yet controlled. Therefore, by adjusting the various variables in Equation 1, a desired flow will be achieved. Thus, based on the size and / or quantity of ventilations around the septum, the catheter assembly design will provide personalized, controlled and predictable blood flow around the septum 50 or 150. In some embodiments, it is desirable to allow flow slow and controlled blood flow as a means to provide a visual indicator that the catheter is in the blood vessel, without the risk of immediate exposure to blood. In other embodiments, it is desirable to allow only air to pass through the vents.
    [0072] [072] Referring now to Figure 6A, a cross-sectional view of an inner lumen of a catheter adapter 14 is shown. In some embodiments, catheter adapter 14 includes a front fluid chamber 62 and a rear fluid chamber 64 fluidly connected via a channel or narrow port 160. As configured and in some embodiments, a fluid aisle 170 is defined by which a fluid 146 flows downstream of the rear fluid chamber 64, through the port 160 and to the front fluid chamber 62. The fluid aisle 170 continues through the front fluid chamber 62 and exits distal end 32 to a catheter (not shown) or other downstream conduit. While fluid 146 fills the entire lumen of catheter adapter 14, fluid aisle 170 is generally restricted to a narrow aisle through a central part of the cross section of catheter adapter 14. Thus, fluid 146 which is not part of the narrow fluid corridor 170 stagnates or circulates in the dead zones 156. The fluid 146 trapped in these dead zones is prevented from mixing sufficiently with the fluid 146 in the fluid corridor 170. In some embodiments, stagnation results in localized and increased concentrations of chemicals, body fluids and / or medications that can lead to precipitation, clotting or administration of dangerously high doses of medications. Therefore, in some embodiments of the present invention, a septum activator 80 is provided with features to eliminate dead zones 156 in the lumen of the catheter adapter 14.
    [0073] [073] Referring now to Figure 6B, a perspective view of the septum activator 80 is shown. In some embodiments, the distal end 84 of the tubular body 82 comprises a first diameter 100 that is smaller than a second diameter 102 of the proximal end 86. The narrowest distal end 84 is configured to insert into the entrance 54 of the septum 50, while the larger proximal end 86 is configured to sit in the rear chamber 64 of the catheter adapter 14. In some embodiments , the septum activator additionally includes a tapered intermediate section 104 to couple the distal 84 and proximal 86 ends.
    [0074] [074] In some embodiments, the proximal end 86 of the septum activator 80 additionally includes a retaining spring 110. The retaining spring 110 generally comprises an outwardly sloping portion of the tubular body 82 configured to engage a retaining groove 68 in a compatible manner. septum activator, as shown in Figures 5A and 7 to 8. The interaction between the retaining spring 110 and the groove 68 limits the lateral movement of the septum activator 80 in lumen 16 of the catheter adapter 14. Thus, the width of the groove retainer 68 determines or limits the path distance to the septum activator 80 on the catheter adapter 14. Additionally, the interaction between the retention spring 110 and the groove 68 prevents removal of the septum activator 80 from the catheter adapter 14. In some embodiments, the septum activator 80 comprises a plurality of retaining springs 110, while in other embodiments the septum activator 80 comprises a single retaining spring 110.
    [0075] [075] In some embodiments, the septum activator 80 further comprises features to direct or deflect the flow of fluid around and / or through the septum activator 80. The deviation of the flow can be important to prevent fluid stagnation or clotting in the dead zones 156 of the septum activator 80 and / or the lumen 16 of the catheter adapter 14 resulting in blockages. Additionally, stagnation of fluid flow through catheter assembly 101 can result in an accumulation of undesirable concentrations of medications in catheter adapter 14 and / or septum activator 80, as previously discussed. High undesirable concentrations can result in inefficient treatment causing serious side effects, including death. Thus, in some embodiments, the septum activator 80 is modified to include flow deflectors 120 and channels for flow diversion 130 to provide a flowable catheter assembly system 101.
    [0076] [076] Flow deflectors 120 generally comprise parts angled in and out of the outer surface of the septum activator 80. Flow deflectors 120 are positioned so that they project in a flow path through the catheter adapter 14. Thus, as the fluid makes contact with the flow deflectors 120 the fluid flow path is disturbed. This disturbance results in the redirection of fluid flow both through the inner lumen 88 of the septum activator 80 and between the outer surface of the septum activator 80 and the inner surface 24 of the catheter adapter 14. In some embodiment, the retention spring 110 it also serves as a flow deflector 120.
    [0077] [077] A flow diversion channel 130 is provided to allow fluid exchange between the lumen of the catheter adapter 16 and the internal lumen 88 of the septum activator 80. Thus, the flow diversion channel 130 prevents stagnation and / or fluid clogging between the inner surface 24 of the catheter adapter 14 and the outer surface of the septum activator 80. In some embodiments, the flow diversion channel 130 comprises a window or entrance to the surface of the tubular body 82. In in other embodiments, the flow diversion channel 130 further comprises an angled flap or surface to further direct the fluid to flow through channel 130.
    [0078] [078] The proximal end 86 of the septum activator 80 additionally includes a contact surface 140. The contact surface 140 comprises the part of the most proximal end of the septum activator 80 and is positioned in the rear chamber 64 of the adjacent catheter adapter 14 to the proximal inlet 26 of the catheter adapter 14, as shown in Figure 7, below.
    [0079] [079] Referring now to Figure 6C, a modality of a septum activator 180 is shown as positioned in the lumen of a catheter adapter 14 (shown in skeleton). In some embodiments, the septum activator 180 is configured to include various recirculation features. For example, in some embodiments, septum activator 180 includes several ventilations 200 configured to divert fluid from the aisle to fluid 170 to dead zones 156. Thus, as fluid flows to and through septum activator 180, the fluid in the septum activator 180 passes through the vents 200 and enters the dead zones 156 between the outer surface of the activator 180 and the surface of the inner wall of the catheter adapter 14. The bypassed fluid mixes with the fluid in the dead zones 156 to gush out the fluid from dead zones 156 and then prevents stagnation and / or excessive concentration, as previously discussed.
    [0080] [080] In some embodiments, septum activator 180 is further modified to include jet removal fins 220. Jet removal fins 220 generally comprise the perpendicular extension of the outer surface of activator 180 that extends to dead zones 156 between the activator 180 and the inner wall surface of the catheter adapter 14. The jet removal fins 220 are provided to divert and redirect the fluid in the corridor for fluid 170 to the dead zones 156. As such, the fluid in the zones dead 156 is intermixed with the fluid in the fluid aisle 170 to prevent stagnation and / or excessive fluid concentration in the catheter adapter 14.
    [0081] [081] Finally, in some embodiments, the flow deflection channel 130 is modified to include a flow deflector 230. The flow deflector 230 comprises a chamfered distal surface of the flow deflection channel 130 positioned to deflect the fluid in the fluid aisle 170 for the dead zones 156 of the front fluid chamber 62. Thus, as fluid 146 flows through the septum activator 180, a portion of the fluid is diverted through the flow diversion channel 130 and into the zone dead 156 through flow deflector 230, as shown in Figure 6D.
    [0082] [082] With continued reference to Figure 6D, a septum activator 180 in cross section is positioned on a catheter adapter 14 in cross section. As previously discussed, the recirculation characteristics can be added to both the proximal 86 and distal end 186 of the septum activator 180. In some embodiments, the proximal end 86 of the septum activator 180 is modified to include curved window features 240 that redirect the flow of a fluid 246 to the dead zones 156 of the rear fluid chamber 64. Thus, the curved surface 242 of the window feature 240 alone and / or in combination with other recirculation features promotes the intermixing of the fluid in the dead zones 156 to prevent stagnation and excessive concentration of fluids in the catheter adapter 14.
    [0083] [083] In some embodiments, the recirculation characteristics are positioned in a symmetrical configuration to induce better jet removal. In other embodiments, the recirculation characteristics are positioned in an asymmetrical configuration to induce better jet removal. Finally, in some embodiments, the recirculation characteristics are used in combination with the diffusion, circulation and recirculation characteristics of the septum activator 180 to assist in the ability to jet-remove fluid from the septum activator 180. In light of Previous disclosure, the additional surfaces of the septum activator 180 can be modified to increase or decrease the efficiency of flow, mixing and jet removal of the fluids in the septum activator 180, as desired.
    [0084] [084] Referring now to Figure 7, a cross-sectional view of the assembled catheter assembly 101 before septum activation 50 via septum activator 80 is shown. Before activation, septum activator 80 it is fully positioned in the rear fluid chamber 64 of catheter adapter 14. Additionally, the retaining springs 110 are engaged in the retaining groove 68 and positioned close to the proximal end of the retaining groove 68. The contact surface 140 of the septum activator 80 is positioned close to the entrance 26 of the catheter adapter 14, such that a proximal entrance 142 of the septum activator 80 is in a plane generally parallel to the plane of the entrance of the catheter adapter 26. Finally, the retaining springs angled outward 110 attach to the surface of the groove 68, thereby maintaining the inactivated position of the septum activator 80 on the catheter adapter 14.
    [0085] [085] Referring now to Figure 8, a cross-sectional view of the catheter assembly 101 is shown, which follows the activation of the septum 50 through the septum activator 80. At the insertion of the coupler 42 at the proximal inlet 26 of the catheter adapter 14, the probe part 46 of the coupler 42 makes contact with the contact surface 140 of the septum activator 80. The septum activator 80 is advanced in a distal direction 390 as the coupler 42 is further inserted at the proximal inlet 26 of the catheter adapter 14. As the coupler 42 is advanced further into the proximal inlet 26, the probing surface 90 of the septum activator 80 crosses the surface of the septum barrier 52. As such, the surface probe 90 of the septum activator 80 is positioned in the front chamber 62 providing a fluid passageway through the septum 50.
    [0086] [086] In some embodiments, the catheter assembly 101 is configured to allow the septum activator 80 to return to a position entirely in the rear chamber 64 following the removal of the coupler 42 from the catheter adapter 14. Thus, when the coupler 46 is removed or released from the catheter assembly 101, the fluid aisle through the septum 50 is closed again. In some embodiments, the retaining spring 110 is configured to flex inwardly in contact between the contact surface 140 of the septum activator 80 and the probe 46 of the coupler 42. When the retaining spring 110 flexes inward, the surface of the probe 90 of the septum activator 80 is temporarily advanced in a distal direction 390 to slit slits 66 and 56 or drain hole 58. When contact between probe 46 and contact surface 140 ends, the spring retention 110 returns to its relaxed position. The relaxed position removes the probing surface 90 of the septum activator 80 from the surface of the barrier 52, thereby allowing slits 66 and 56 to close.
    [0087] [087] Referring now to Figure 9, a cross-sectional view of a catheter assembly 300 which incorporates an introducer needle 350 is shown. The proximal end 352 of needle 350 can be coupled to a needle hub ( (not shown) or an insert assembly (not shown) to facilitate a user in retaining and manufacturing the 350 needle during catheterization. For clarity fins in this illustration, the rest of the needle assembly has been removed.
    [0088] [088] Prior to activation, the septum activator 380 is fully positioned in the rear chamber 364 of the catheter adapter 314. A runner is provided through the internal lumen 316 of the activator 380 to allow passage of the introducer needle 350. A portion intermediate needle 350 passes through septum 356 and continues through front chamber 362 and into flexible catheter 312. A portion of the tip (not shown) of needle 350 extends beyond a portion of the tip (not shown) of catheter 312 such that the tip of the needle is available to gain access to a patient's vasculature.
    [0089] [089] Slit 366 of septum 356 is opened by introducer needle 350. In some embodiments, a seal forms between the outer surface of needle 350 and slit 366. Thus, fluid and air flows are prevented from deflecting from the septum through the interface between needle 350 and slot 366. In some embodiments, a channel or aisle is provided between slot 366 and needle 350 to allow controlled flow or flow between these two components.
    [0090] [090] In other embodiments, a lubricant such as a non-wetting lubricant is applied at the interface between the needle 350 and the slot 366 to further eliminate the possible leakage of fluid and / or air. A non-wetting lubricant can also be beneficial to prevent tearing or other damage to the crack that can occur when the needle is removed from the catheter assembly following catheterization. A non-wetting lubricant can also facilitate proper realignment of the slit 366 halves following removal of needle 350. Non-limiting examples of a non-wetting lubricant include the Teflon-based non-wetting materials known as Endura, from Endura Coating Co .; A20, E-20, 1000-S20, FEP Green, PTFE and X-40 from Tiodize; Cammie 2000 from AE Yale; 21845 from Ladd Research; MS 122-22, MS 122DF, MS-143DF, MS-122V MS-122VM, MS143V, MS-136W, MS-145W, U0316A2, U0316B2, MS-123, MS125, MS-322 and MS-324 from Miller-Stepheson ; and Otto Bock 633T2 can also be used. Various non-Teflon based non-wetting lubricant materials include Dylyn, from ART; Nyebar, Diamonex, NiLAD, TIDLN, Kiss-Cote, Titanium oxide; Fluoro Chemical coating Fluocad FC-722, from 3M; Dupont Permacote; Plasma Tech 1633 by Plasma Tech, Inc .; and silicone sprayers.
    [0091] [091] In some embodiments, the distal end 384 of the septum activator 380 is elongated such that the contact surface 340 is positioned closer to the proximal inlet 326 of the catheter adapter 314. In this way, a coupler provided with a probe part shortened (not shown) can make sufficient contact with the contact surface 340 to advance the distal end 384 through the septum 356. In other embodiments, the distal end 384 of the septum activator 380 is configured to include an internal diameter of substantially equal size and the outer diameter of the introducer needle 350. As such, the inner diameter of the distal end 384 is configured to allow the needle 350 to pass while maintaining minimum tolerance 382 between the outer surface of the needle 350 and the inner surface of the needle. distal end 384 of the septum activator 380. This minimum tolerance 382 provides a seal, thereby preventing leakage or blood flow between the water 350 and septum activator 380 while removing needle 350 from catheter assembly 300.
    [0092] [092] In some embodiments, a translation slot 368 is provided in the rear chamber 364. The translation slot 368 generally comprises an annular recess provided with a determined length 370. The translation slot 368 is additionally configured to receive removal fins by jet 320 such that the jet removal fins 320 are retained in the groove 368. Thus, the length 370 represents the maximum lateral distance that the septum activator 380 is allowed to travel in the rear chamber 364. In some embodiments, a proximal end of groove 368 is defined by an annular edge 372. In other embodiments, a distal end of the groove 368 is defined by a second annular edge 374. Still, in other embodiments, the second annular edge 374 forms a proximal end of the septum canal 60.
    [0093] [093] Referring now to Figure 10, there is shown a cross-sectional view of a catheter assembly 300 that follows the removal of the introducing needle 350. In the removal of the introducing needle 350, the slot 366 of the septum 356 does not it is more slanted open and therefore closes again and seals to prevent the flow of fluids and / or air through the slit 366. As previously discussed, in some embodiments, the slit 366 includes a drainage hole (not shown) for allow controlled flow between the front and rear chambers 362 and 364. In other embodiments, a plurality of ventilation channels 70 are provided between the outer surface of the septum 356 and the septum channel 60.
    [0094] [094] Referring now to Figures 11A through 11D, septum 356 can include various configurations and features to stabilize the distal end 384 of septum activator 380. For example, in some embodiments, septum 356 is configured to include an internal diameter 358 dimensioned substantially equal to the external diameter of the distal end 384 of the septum activator 380, as shown in Figure 11A. In other embodiments, the septum 356 is configured to have an internal annular edge or protuberance 360 provided with an internal diameter 358 dimensioned substantially equal to the external diameter of the distal end 384, as shown in Figure 11B. Thus, in both modalities, the distal end 384 is radially supported by the septum 356.
    [0095] [095] With reference to Figure 11C, in some embodiments, an internal surface 376 of septum 356 is modified to include one or more reliefs 391. In some embodiments, relief 391 comprises a concave annular recess configured to receive a positive feature 392 that comprises a part of the distal end 384 of the septum activator 380. In other embodiments, the relief 391 comprises a single indentation sized and configured to receive the characteristic 392 of the septum activator 380. Still, in other embodiments, the relief 391 comprises a characteristic positive and feature 392 comprises a negative or indented feature (not shown). Thus, in some embodiments, the interaction between relief 391 and feature 392 provides both radial support and axial retention of the septum activator 380 on catheter adapter 314. This configuration can eliminate the need for additional retention features, such as staples and retaining slots.
    [0096] [096] Referring now to Figure 11D, septum 356 includes a domed profile 394 to oppose the pressure applied to the distal side 386 of septum 356 following removal of the introducing needle 350. The domed profile 394 provides additional strength to the distal side 386 of the septum 356, thereby increasing the fluid pressure required to annul the septum 356. In some embodiments, as the blood reaches the septum 356 the domed profile 394 assists the septum 356 in closing due to the pressure of the blood flow in the front chamber 362. In other embodiments, the septum 356 comprises a generally flat profile, as shown in Figures 5A, 5B and 7 through 11C or may include a combination of flat and curved surfaces (not shown).
    [0097] [097] Referring now to Figure 12, there is shown a cross-sectional view of a catheter assembly 300 that follows the activation of the septum 356 by means of the septum activator 380. When inserting a coupler 342 at the entrance proximal 326 of the catheter adapter 314, the probe part 346 of the coupler 342 makes contact with the contact surface 340 of the septum activator 380. The septum activator 380 is thus advanced in a distal direction 390 as the coupler 342 is additionally inserted into the proximal inlet 326, thereby causing the jet removal fins 320 to translate into the translation groove 368. As coupler 342 is advanced further into the proximal inlet 326, the probing surface 348 of the septum activator 380 passes through slit 366 of septum 356. As such, the probing surface 348 of septum activator 380 is positioned in front chamber 362 providing a fluid passageway through septum 356.
    [0098] [098] Referring now to Figures 13 to 20, numerous valves according to some modalities are shown, which aim to eliminate or further reduce the areas of little or no fluid flow that occurs in a vascular access device which contains a valve mechanism comprising a septum and septum activator or pusher.
    [0099] [099] Figures 13 and 14 show an embodiment of the invention in which a sleeve 45 is used to prevent fluid from flowing into the interstitial spaces that are areas with little or no fluid flow.
    [0100] [0100] Figure 13 shows a septum 43 that forms a fluidic seal in lumen 341 of the body of catheter 41 after removal of the needle, with the septum activator or pusher 344 in the proximal position. Sleeve 45 is secured around pusher 344 to form a fluid seal between an outer periphery 53 of proximal part 348 of pusher 344 and an inner surface 354 of lumen 341. Thus, no fluid can flow between the proximal end of pusher 344 and the inner surface 354 of the lumen 341 to the interstitial space 498. Figure 14 shows the pusher 344 in the distal position in which the fluid can only flow through the lumen 51 of the pusher 344. The sleeve 45 still maintains a fluidic seal between the outer periphery 53 of pusher 344 and inner surface 54 of lumen 341. Thus, no fluid can flow into the interstitial spaces 498. In addition, the tapered outer surface 351 of the distal portion of the sleeve 45 reduces the size of the interstitial space 498 when the pusher 344 is in the distal position. Sleeve 45 is made of a softer elastic material, such as liquid silicone rubber, for example, and is attached to pusher 344 through suitable molding procedures, such as insertion molding, injection molding and other molding techniques or a combination of molding techniques.
    [0101] [0101] Figures 15 and 16 show another embodiment of the invention that has the valve mechanism that uses a seal at the proximal end 65 and the distal end 75 of a tubular septum activator 365, to prevent fluid from flowing into the spaces interstitials 698 and 699 between the activator 365 and the inner surface 74 of the lumen 363 of the catheter body 61. The distal seal 75 is incorporated in the septum 63 to prevent any fluid from flowing between the distal end of the activator 365 and the proximal surface of the septum 63 when the pusher is in the proximal position as shown in Figure 15 or the distal position as shown in Figure 16. The proximal seal 65 is a toroidal-shaped or cylindrical ring strap that continues around the outer circumference of the proximal end of the activator 365 that forms a fluid seal with the inner surface 74 of the lumen 363 of the catheter body 61 in both the proximal and distal positions of the activator. The proximal seal 65 is made of a softer elastic material, such as liquid silicone rubber, for example, and is overmoulded on activator 365 and retained in position by edge 367 on the outer surface of the proximal end of activator 365. Activator 365 has numerous fins 369 that extend from the circumference and are evenly distributed around the circumference of the outer surface 371. These fins 369 are long enough to make contact with part 73 of the inner surface 74 of the lumen 363 and are used to limit the movement of the activator 365 along the catheter body by contact with the septum 63 in the distal direction and make contact with the indentation or step 378 of the inner surface 74 in the proximal direction.
    [0102] [0102] Figures 17 to 20 show some modalities equipped with valve mechanisms that are configured to exclude small confined interstitial spaces, thereby eliminating the areas of fluid flow little by little.
    [0103] [0103] Figures 17 and 18 show a modality in which the septum 83 covers most of the activator 383. The activator 383 includes a head section, tubular section and a plunger. Plunger 381 having a diameter at least equal to that of lumen 385 of catheter body 81 such that no fluid can pass between the inner surface 94 and plunger 80 is located at the proximal end of activator 383. Septum 83 has an outer diameter at least equal to that of lumen 82 along its entire length such that no interstitial space is present between the septum 83 and the inner surface 94 of lumen 385. In addition, septum 83 has a lumen 85, the inner diameter that is equal to the outer diameter of tubular section 87 of activator 383, thereby forming an additional fluid seal along the length of tubular section 87. Furthermore, the relative lengths of activator 383 and septum 83 are such that the distal face 389 of the plunger 381 is in close contact with the proximal end 388 of the septum 83 when the activator 383 is in the distal position, as shown in Figure 18. Thus, there is no interstitial space between the plunger 381 and the septum 83. The section of head is located at the distal end of activator 383 and includes longitudinal grooves 387 on the side wall of lumen 91 to allow fluid flow to deviate out of lumen 91 of activator 383 and reduces the possibility of an area of little or no flow 393 around the distal face of the septum 83 on the inner surface 74.
    [0104] [0104] Figures 19 and 20 show an additional embodiment of a valve mechanism in which a septum 103 includes a tubular section 107 provided with a distal end 108 and a membrane section 109 provided with a proximal planar surface located at the proximal end 105. The tubular section 107 of the septum 103 is substantially disposed in the septum housing 111 and is prevented from distal movement by the annular shoulder or recess 121 formed on the surface of the lumen 385. A fluidic seal is formed between the peripheral of the membrane section 109 and the inner surface 114 of the proximal section 110 of the lumen 385 to prevent leakage of fluid past the septum 103 when the valve closes. In some embodiments, the septum 103 additionally includes a needle slot 113 or valve opening located around the center of the membrane section 109, which extends through the membrane section 109, to facilitate penetration of the septum 103 by the introducing needle 5 A septum activator 304 is located in the proximal section of the lumen 385 and includes a tubular part 115. In some embodiments, the tubular or sleeve part 115 additionally includes a plurality of longitudinal grooves or channels for flow 116 on the sidewall, evenly distributed around the circumference of the tubular part 115 and located at the distal or driving end 117 such that a gap is formed between the driving end 117 and the membrane 109.
    [0105] [0105] Figure 19 shows the septum activator 304 in the proximal position following removal of the introducing needle 5. In particular, the driving end 117 of the septum activator 304 is positioned against the proximal planar surface of the septum membrane section 109 103 to form an interface. The diameter of the lumen 385 in the proximal section 310 is approximately equal to the outer diameter of the cube 106 (for example, a luer cube) of a vascular access device, the septum activator 304 and the membrane section 109, such that there are no spaces interstitials between the hub 106 (shown in Figure 20), a contact end of the septum activator 304 and the membrane section 109. The inner surface 114 and the proximal section 310 of the first lumen 385 are further sealed by the membrane section 109.
    [0106] [0106] Referring now to Figure 20, septum activator 304 is shown in the distal position whereby cube 106 has repositioned septum activator 304 in a distal direction, thereby causing the drive end 117 of the septum activator 304 deforms the membrane section 109. This deformation results in the formation of a fluid corridor by means of which the fluid diverts from the membrane section 109 by means of grooves 116, consequently flowing between the periphery of the membrane section 109 and the inner surface 114, and is guided through the inlet 118 in the side wall of the tubular part 107. This divergent fluid path around the periphery of the membrane section 109 causes a turbulent fluid flow that reduces the possibility of stagnation or a low flow area that occurs near the shoulder 119 in the lumen 385. The fluid then continues to flow along the inner diameter of the tubular part 107 and into the distal section 112 of the lumen 385.
    [0107] [0107] Any septum described herein can be made from a variety of suitable materials and through a variety of suitable manufacturing methods. For example, the septum can be formed of liquid silicone rubber through suitable molding procedures, such as insertion molding, injection molding, other molding techniques or a combination of molding techniques. The septum 103 or any septum described herein can also include a coating of antimicrobial substance on any of its surfaces, especially those surfaces that have contact with the fluid.
    [0108] [0108] The present invention can be incorporated in other specific forms without separating from its structures, methods or other essential characteristics, as widely described herein and claimed hereinafter. The described modalities must be considered, in all senses, as illustrative and not restrictive. The scope of the invention is therefore indicated by the appended claims instead of the previous description. All changes that are within the meaning and variation of equivalence of the claims must be included in their scope.
    权利要求:
    Claims (20)
    [0001]
    System to control the flow of fluid in a catheter assembly (101), which comprises: an intravenous catheter assembly (101) provided with a catheter adapter (14) and a needle hub, the catheter adapter having an internal lumen (16); a septum (50) disposed in a part of the internal lumen; a slit (56) formed through the septum (50); an introducer needle (5) having a first end and a second end, the first end being coupled to the needle hub and the second end extending through the inner lumen (16) of the catheter adapter, an intermediate part of the introducer needle (5 ) being positioned in a part of the septum (50); Characterized by a Parilene coating will be disposed in the slit (56) of the septum (50), the Parilene coating having a thickness between approximately 0.00005 and 0.0005 mm.
    [0002]
    System, according to claim 1, CHARACTERIZED by the fact that the thickness of the Parilene coating is between 0.0001 to 0.0002 mm.
    [0003]
    System according to claim 1, CHARACTERIZED by the fact that it additionally comprises a ventilation channel (70) interposed between the septum (50) and an internal surface (24) of the internal lumen (16) of the catheter adapter, the channel of ventilation having a surface area and a perimeter selected to allow at least one of the air and blood to pass through at a desired flow rate.
    [0004]
    System according to claim 1, CHARACTERIZED by the fact that it additionally comprises a septum activator (80) disposed in a position of the internal lumen adjacent to the septum (50), a distal end (84) of the septum activator (80) which makes contact with a proximal surface of the septum, and a proximal end (86) of the septum activator which is positioned adjacent to an entrance of the catheter adapter, where the proximal end (86) of the septum activator (80) is accessed when inserting an external device into the catheter adapter port.
    [0005]
    System according to claim 2, CHARACTERIZED by the fact that it additionally comprises a lumen that forms a fluid corridor (170) through the septum activator (80), the lumen having an internal diameter configured to allow the passage of the introducing needle .
    [0006]
    System according to claim 3, CHARACTERIZED by the fact that the septum activator (80) comprises a plurality of ventilations and flow deviations (120) configured to improve the circulation of a fluid in at least one of the septum activator ( 80) and an interstitial space between the septum activator and the inner surface of the inner lumen.
    [0007]
    System, according to claim 3, CHARACTERIZED by the fact that it additionally comprises flow ventilation interposed between an external surface of the introducing needle (5) and an internal surface of the lumen of the septum activator (88), in which a rate of flow through flow ventilation is determined by adjusting at least one outer diameter of the introducing needle (5) and the inner diameter of the lumen of the septum activator (88).
    [0008]
    Method that manufactures a catheter assembly equipped with features to control the flow of fluid in the catheter assembly (101), the method comprising: providing an intravenous catheter assembly (101) provided with a catheter adapter (14) and a needle hub, the catheter adapter having an internal lumen (16); having a septum (50) in the internal lumen (16), the septum being provided with a slit (56) between it; position an introducer needle (5) on the catheter adapter (14), where a first end of the introducer needle is coupled to the needle hub and a second end of the introducer needle extends through the internal lumen of the catheter adapter (14), an intermediate part of the introducing needle being positioned in a part of the septum (50); Characterized by coat the septum (50) and the crack (56) with a Parilene coating that has a thickness between approximately 0.00005 and 0.0005 mm.
    [0009]
    Method, according to claim 8, CHARACTERIZED by the fact that the thickness of the Parilene coating is between 0.0001 to 0.0002 mm.
    [0010]
    Method according to claim 8, CHARACTERIZED by the fact that it additionally comprises interposedly positioning a ventilation channel (70) between the septum (50) and an internal surface of the internal lumen of the catheter adapter (14), the ventilation channel (70) having a surface area and a perimeter selected to allow at least one of the air and blood to pass through at a desired flow rate.
    [0011]
    Method according to claim 8, CHARACTERIZED by the fact that it additionally comprises arranging a septum activator (80) in a part of the inner lumen adjacent to the septum (50), a distal end (84) of the septum activator (80) which makes contact with a proximal surface (52) of the septum (50), and a proximal end of the septum activator (80) being positioned adjacent to a catheter adapter inlet, where the proximal end of the septum activator (80) is accessed by inserting an external device into the catheter adapter port.
    [0012]
    Method according to claim 9, CHARACTERIZED by the fact that it additionally comprises providing a lumen that forms a fluid corridor (170) through the septum activator (80), the lumen having an internal diameter configured to allow the needle to pass introducer (5).
    [0013]
    Method according to claim 10, CHARACTERIZED by the fact that it further comprises modifying the septum activator (80) to include a plurality of ventilations and flow deviations (120) configured to improve the circulation of a fluid in at least one of the septum activator (80) and an interstitial space between the septum activator and the inner surface of the inner lumen.
    [0014]
    Method according to claim 10, CHARACTERIZED by the fact that it additionally comprises providing flow ventilation interposed between an external surface of the introducing needle and an internal surface of the lumen of the septum activator (88), in which a flow rate through Flow ventilation is determined by adjusting at least one outer diameter of the introducing needle and the diameter of the lumen of the septum activator.
    [0015]
    Assembly of an intravenous catheter (300), comprising: a catheter adapter (314) having an inner lumen (316), the inner lumen has a proximal end, a distal end and an intermediate part; a recess that forms the middle part of the inner lumen; a septum (356) disposed in the recess, the septum (356) forming an annulled barrier between the proximal end and the distal end of the inner lumen; an introducer needle (350) positioned in the internal lumen (316), a part of the needle extends through the internal lumen, such that a part of the tip of the introducer needle (350) extends beyond the catheter adapter (314), a part the introducing needle is inserted through the septum (356); a septum activator (380) positioned at the proximal end of the inner lumen, the septum activator having a corridor through which the introducing needle (350) is inserted, the septum activator additionally having a first end to open a slit ( 366) the septum (356), and a second end having a contact surface; and an entry that forms a proximal end of the catheter adapter, in which an external device is inserted through the entry to make contact with the septum activator contact surface (380), thereby advancing the first end of the septum activator through the slit (366) of the septum (356); CHARACTERIZED by a Parilene coating is disposed in a slit (366) of the septum (356), the Parilene coating having a thickness between approximately 0.00005 and 0.0005 mm.
    [0016]
    Assembly, according to claim 15, CHARACTERIZED by the fact that the thickness of the Parilene coating is between 0.0001 to 0.0002 mm.
    [0017]
    Assembly according to claim 15, CHARACTERIZED by the fact that it additionally comprises a ventilation channel (70) interposed between the septum (356) and an internal surface of the internal lumen (316) of the catheter adapter, the ventilation channel ( 70) having a surface area and a perimeter selected to allow at least one of the air and blood to pass between the proximal end and the distal end of the internal lumen, at a desired flow rate.
    [0018]
    Assembly according to claim 15, CHARACTERIZED by the fact that it additionally comprises flow ventilation interposed between an external surface of the introducing needle (350) and an internal surface of the septum activator (380), in which a flow rate through Flow ventilation is determined by adjusting at least one outer diameter of the introducer needle (350) and the inner diameter of the septum activator aisle (380).
    [0019]
    Assembly according to claim 15, CHARACTERIZED by the fact that the septum activator (380) additionally comprises a plurality of ventilations and flow deviations configured to improve the circulation of a fluid in at least one of the septum activator aisle and of an interstitial space between the septum activator (380) and the inner surface of the inner lumen (316) of the catheter adapter.
    [0020]
    Assembly according to claim 15, CHARACTERIZED by the fact that a proximal surface of the septum (356) additionally includes a cavity to accommodate a distal end of the septum activator (380), and in which a distal surface of the septum (356) has the domed shape.
    类似技术:
    公开号 | 公开日 | 专利标题
    BR112013022947B1|2021-02-17|system for controlling fluid flow in a catheter assembly, a method that manufactures a catheter assembly and intravenous catheter assembly
    AU2018202356B2|2019-05-16|Systems and methods for providing a flushable catheter assembly
    US9114241B2|2015-08-25|Systems and methods for providing a flushable catheter assembly
    USRE45896E1|2016-02-23|Systems and methods for providing a catheter assembly
    同族专利:
    公开号 | 公开日
    CN103476450B|2017-09-26|
    AU2012226231A1|2013-09-19|
    JP2014515627A|2014-07-03|
    US8679063B2|2014-03-25|
    AU2012226231B2|2016-08-11|
    MX351917B|2017-11-03|
    ES2630019T3|2017-08-17|
    MX2013010165A|2013-11-20|
    EP2683432A1|2014-01-15|
    WO2012121843A1|2012-09-13|
    CA2828697A1|2012-09-13|
    EP2683432B1|2017-04-05|
    JP6401906B2|2018-10-10|
    CN103476450A|2013-12-25|
    CA2828697C|2019-03-05|
    US20110160663A1|2011-06-30|
    BR112013022947A2|2016-12-06|
    CN202682525U|2013-01-23|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    DE2817102C2|1978-04-19|1985-01-24|Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg|Connector for plastic cannulas or venous catheters|
    US4449693A|1982-09-30|1984-05-22|Gereg Gordon A|Catheter check valve|
    GB8527646D0|1985-11-08|1985-12-11|Cox J A|Devices for sampling drainage|
    GB8627808D0|1986-11-20|1986-12-17|Cox J A|Sampling liquids from human/animal body|
    US4842591A|1988-01-21|1989-06-27|Luther Ronald B|Connector with one-way septum valve, and assembly|
    DE3809127C1|1988-03-18|1989-04-13|B. Braun Melsungen Ag, 3508 Melsungen, De|
    US5064416A|1988-05-26|1991-11-12|Newgard Kent W|Self-occluding intravascular cannula assembly|
    US4874377A|1988-05-26|1989-10-17|Davis Newgard Revocable Family Living Trust|Self-occluding intravascular cannula assembly|
    US5053014A|1990-02-01|1991-10-01|Critikon, Inc.|Catheter with controlled valve|
    US5041097A|1990-02-26|1991-08-20|Johnson Gerald W|Intravenous catheter fitting with protective end seal|
    US5062836A|1990-03-14|1991-11-05|The Kendall Company|Placement device for a catheter and guide wire|
    US5084023A|1990-03-22|1992-01-28|Critikon, Inc.|Bloodless catheter with self-shielding needle|
    US5127905A|1990-05-02|1992-07-07|Critikon, Inc.|Stickless catheter with manual shut-off valve|
    US5108374A|1990-05-02|1992-04-28|Critikon, Inc.|Stickless catheter with manual shut-off valve|
    US5085645A|1990-08-15|1992-02-04|Becton, Dickinson And Company|Apparatus and method for a catheter adapter with valve|
    US5154703A|1990-10-30|1992-10-13|Care Medical Devices, Inc.|Bloodless catheter|
    US5156596A|1991-02-04|1992-10-20|Menlo Care, Inc.|Catheter with changeable number of lumens|
    US5295969A|1992-04-27|1994-03-22|Cathco, Inc.|Vascular access device with air-tight blood containment capability|
    US5234410A|1992-10-23|1993-08-10|Vlv Associates|Catheter assembly|
    US5330435A|1993-04-08|1994-07-19|Vaillancourt Vincent L|Valve for a catheter assembly|
    DE4311715C2|1993-04-08|1996-02-01|Fresenius Ag|Port cannula|
    US5350363A|1993-06-14|1994-09-27|Cordis Corporation|Enhanced sheath valve|
    US5657963A|1993-06-16|1997-08-19|United States Surgical Corporation|Seal assembly for accommodating introduction of surgical instruments|
    US5352205A|1993-09-16|1994-10-04|Lawrence Dales|Bloodless insertion catheter assembly|
    JP2584597B2|1993-09-29|1997-02-26|ベクトン・ディッキンソン・アンド・カンパニー|Catheter introduction device with blood seal|
    US5806831A|1993-10-13|1998-09-15|Paradis; Joseph R.|Control of fluid flow with internal cannula|
    US5549577A|1993-12-29|1996-08-27|Ivac Corporation|Needleless connector|
    US5522804A|1994-02-15|1996-06-04|Lynn; Lawrence A.|Aspiration, mixing, and injection syringe|
    US5405323A|1994-02-22|1995-04-11|Aeroquip Corporation|Catheter check valve assembly|
    US5487728A|1994-05-19|1996-01-30|Vaillancourt; Vincent L.|Connector assembly|
    US5549566A|1994-10-27|1996-08-27|Abbott Laboratories|Valved intravenous fluid line infusion device|
    DE4442352C1|1994-11-29|1995-12-21|Braun Melsungen Ag|Valve arrangement provided in connector for use e.g. with cannula|
    US5520666A|1994-12-06|1996-05-28|Abbott Laboratories|Valved intravenous fluid line connector|
    US5575769A|1995-05-30|1996-11-19|Vaillancourt; Vincent L.|Cannula for a slit septum and a lock arrangement therefore|
    IT1285266B1|1996-02-26|1998-06-03|Borla Ind|CONNECTOR WITH PROTECTION VALVE FOR INFUSION / TRANSFUSION AND SIMILAR MEDICAL LINES.|
    US5817069A|1996-02-28|1998-10-06|Vadus, Inc.|Valve assembly|
    US5651772A|1996-02-28|1997-07-29|Aeroquip Corporation|Needle guard assembly|
    US6273869B1|1996-06-13|2001-08-14|Vincent L. Vaillancourt|Valve connector|
    US5738144A|1996-10-11|1998-04-14|Aeroquip Corporation|Luer connecting coupling|
    JP3752631B2|1996-11-18|2006-03-08|ナイプロ・インク|Swabable lure cone valve|
    US6883778B1|1996-11-18|2005-04-26|Nypro Inc.|Apparatus for reducing fluid drawback through a medical valve|
    US5967490A|1997-01-08|1999-10-19|Vadus, Inc.|Catheter hubs having a valve|
    US5954698A|1997-01-08|1999-09-21|Vadus, Inc.|Catheter apparatus having valved catheter hub and needle protector|
    US5911710A|1997-05-02|1999-06-15|Schneider/Namic|Medical insertion device with hemostatic valve|
    US6117108A|1997-08-20|2000-09-12|Braun Melsungen Ag|Spring clip safety IV catheter|
    NL1007997C2|1998-01-09|1999-07-12|Cordis Europ|Device for inserting an elongated medical device.|
    US6077244A|1998-04-30|2000-06-20|Mdc Investment Holdings, Inc.|Catheter insertion device with retractable needle|
    CN100471535C|1998-05-29|2009-03-25|劳伦斯A·林恩|Luer receiver and method for fluid transfer|
    US6331176B1|1999-03-11|2001-12-18|Advanced Cardiovascular Systems, Inc.|Bleed back control assembly and method|
    CA2380907C|1999-08-12|2009-12-08|Lawrence A. Lynn|Luer receiving vascular access system|
    FR2802432B1|1999-12-16|2002-03-08|Vygon|AUTOMATIC SHUTTER CONNECTOR FOR CONNECTING A LIQUID INJECTION HEAD TO AN INJECTION OUTPUT|
    US6699221B2|2000-06-15|2004-03-02|Vincent L. Vaillancourt|Bloodless catheter|
    MXPA03006522A|2001-01-24|2004-07-08|Becton Dickinson Co|Lubricious coating for medical device.|
    JP4996015B2|2001-03-12|2012-08-08|メディキット株式会社|Indwelling catheter|
    US6837884B2|2001-06-18|2005-01-04|Arthrocare Corporation|Electrosurgical apparatus having compound return electrode|
    JP3808806B2|2002-06-26|2006-08-16|メディキット株式会社|Indwelling needle|
    DE20210394U1|2002-07-04|2002-09-12|Braun Melsungen Ag|catheter introducer|
    US7347839B2|2003-02-12|2008-03-25|Nipro Corporation|Indwelling catheter|
    US7470254B2|2003-08-18|2008-12-30|Medical Components, Inc.|Needle with sealing valve|
    US20070083162A1|2005-10-11|2007-04-12|Span-America Medical Systems, Inc.|Valve for intravenous catheter|
    JP2008043445A|2006-08-11|2008-02-28|Medikit Kk|Catheter, hollow needle and dwelling needle assembly|
    WO2008022258A2|2006-08-16|2008-02-21|Surmodics, Inc.|Methods and materials for increasing the adhesion of elution control matrices to substrates|
    US8062266B2|2006-10-11|2011-11-22|Becton, Dickinson And Company|Vascular access device including a tear-resistant septum|
    US8308691B2|2006-11-03|2012-11-13|B. Braun Melsungen Ag|Catheter assembly and components thereof|
    US8469928B2|2009-02-11|2013-06-25|Becton, Dickinson And Company|Systems and methods for providing a flushable catheter assembly|
    US8679063B2|2009-02-11|2014-03-25|Becton, Dickinson And Company|Systems and methods for providing a catheter assembly|
    US8388583B2|2009-08-20|2013-03-05|Becton, Dickinson And Company|Systems and methods for providing a flushable catheter assembly|AT424879T|2005-07-06|2009-03-15|Vascular Pathways Inc|DEVICE FOR INTRAVENOUS CATHETER INTRODUCTION AND USE METHOD|
    JP4994775B2|2006-10-12|2012-08-08|日本コヴィディエン株式会社|Needle point protector|
    AT548972T|2007-05-07|2012-03-15|Vascular Pathways Inc|INTRAVENOUS CATHETER INTRODUCTION AND BLOOD SPECIMENS|
    US8679063B2|2009-02-11|2014-03-25|Becton, Dickinson And Company|Systems and methods for providing a catheter assembly|
    US9458536B2|2009-07-02|2016-10-04|Sio2 Medical Products, Inc.|PECVD coating methods for capped syringes, cartridges and other articles|
    PL2251454T3|2009-05-13|2014-12-31|Sio2 Medical Products Inc|Vessel coating and inspection|
    US9545360B2|2009-05-13|2017-01-17|Sio2 Medical Products, Inc.|Saccharide protective coating for pharmaceutical package|
    CN102711895B|2009-10-16|2014-09-10|泰尔茂株式会社|Placement needle and placement needle assembly|
    US10384039B2|2010-05-14|2019-08-20|C. R. Bard, Inc.|Catheter insertion device including top-mounted advancement components|
    US8932258B2|2010-05-14|2015-01-13|C. R. Bard, Inc.|Catheter placement device and method|
    US9872971B2|2010-05-14|2018-01-23|C. R. Bard, Inc.|Guidewire extension system for a catheter placement device|
    US9950139B2|2010-05-14|2018-04-24|C. R. Bard, Inc.|Catheter placement device including guidewire and catheter control elements|
    USD903101S1|2011-05-13|2020-11-24|C. R. Bard, Inc.|Catheter|
    USD903100S1|2015-05-01|2020-11-24|C. R. Bard, Inc.|Catheter placement device|
    US8652104B2|2010-06-25|2014-02-18|Smiths Medical Asd, Inc.|Catheter assembly with seal member|
    US9545495B2|2010-06-25|2017-01-17|Smiths Medical Asd, Inc.|Catheter assembly with seal member|
    US9878101B2|2010-11-12|2018-01-30|Sio2 Medical Products, Inc.|Cyclic olefin polymer vessels and vessel coating methods|
    US8690833B2|2011-01-31|2014-04-08|Vascular Pathways, Inc.|Intravenous catheter and insertion device with reduced blood spatter|
    ES2750035T3|2011-02-25|2020-03-24|Bard Inc C R|Medical component insertion device including a retractable needle|
    US9272095B2|2011-04-01|2016-03-01|Sio2 Medical Products, Inc.|Vessels, contact surfaces, and coating and inspection apparatus and methods|
    US8486024B2|2011-04-27|2013-07-16|Covidien Lp|Safety IV catheter assemblies|
    EP2760521B1|2011-09-26|2016-01-06|Covidien LP|Safety iv catheter and needle assembly|
    WO2013048975A1|2011-09-26|2013-04-04|Covidien Lp|Safety catheter|
    US8834422B2|2011-10-14|2014-09-16|Covidien Lp|Vascular access assembly and safety device|
    US11116695B2|2011-11-11|2021-09-14|Sio2 Medical Products, Inc.|Blood sample collection tube|
    EP2776603B1|2011-11-11|2019-03-06|SiO2 Medical Products, Inc.|PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS|
    ITMI20120154A1|2012-02-06|2013-08-07|Enrico Gianluca Bergamaschi|SPINAL ANESTHESIA DEVICE|
    US9108021B2|2012-02-22|2015-08-18|Becton, Dickinson And Company|Low drag, high pressure septum|
    CN104203330B|2012-04-06|2017-04-12|C·R·巴德股份有限公司|Distal valve for a catheter|
    US9352119B2|2012-05-15|2016-05-31|Becton, Dickinson And Company|Blood control IV catheter with antimicrobial properties|
    US9579486B2|2012-08-22|2017-02-28|Becton, Dickinson And Company|Blood control IV catheter with antimicrobial properties|
    ITFO20120021A1|2012-09-28|2012-12-28|Antonio Agnoletti|MOBILE VALVE FOR NEEDLE CANNULA|
    JP6509734B2|2012-11-01|2019-05-08|エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド|Film inspection method|
    WO2014078666A1|2012-11-16|2014-05-22|Sio2 Medical Products, Inc.|Method and apparatus for detecting rapid barrier coating integrity characteristics|
    CN105705676B|2012-11-30|2018-09-07|Sio2医药产品公司|Control the uniformity of the PECVD depositions on injector for medical purpose, cylindrantherae etc.|
    US9764093B2|2012-11-30|2017-09-19|Sio2 Medical Products, Inc.|Controlling the uniformity of PECVD deposition|
    CN108607150B|2013-01-30|2021-01-12|血管通路股份有限公司|Systems and methods for venipuncture and catheter placement|
    US9695323B2|2013-02-13|2017-07-04|Becton, Dickinson And Company|UV curable solventless antimicrobial compositions|
    US9750928B2|2013-02-13|2017-09-05|Becton, Dickinson And Company|Blood control IV catheter with stationary septum activator|
    US20160015898A1|2013-03-01|2016-01-21|Sio2 Medical Products, Inc.|Plasma or cvd pre-treatment for lubricated pharmaceutical package, coating process and apparatus|
    KR102167557B1|2013-03-11|2020-10-20|에스아이오2 메디컬 프로덕츠, 인크.|Coated Packaging|
    US9937099B2|2013-03-11|2018-04-10|Sio2 Medical Products, Inc.|Trilayer coated pharmaceutical packaging with low oxygen transmission rate|
    WO2014144926A1|2013-03-15|2014-09-18|Sio2 Medical Products, Inc.|Coating method|
    US10500376B2|2013-06-07|2019-12-10|Becton, Dickinson And Company|IV catheter having external needle shield and internal blood control septum|
    US9592367B2|2013-07-30|2017-03-14|Becton, Dickinson And Company|Blood control catheter valve employing actuator with flexible retention arms|
    US9717887B2|2013-12-04|2017-08-01|B. Braun Melsungen Ag|Catheter assembly blood control device and related methods|
    US9750925B2|2014-01-21|2017-09-05|Becton, Dickinson And Company|Ported catheter adapter having combined port and blood control valve with venting|
    EP3693493A1|2014-03-28|2020-08-12|SiO2 Medical Products, Inc.|Antistatic coatings for plastic vessels|
    CA2945606A1|2014-04-18|2015-10-22|Becton, Dickinson And Company|Needle capture safety interlock for catheter|
    US9789279B2|2014-04-23|2017-10-17|Becton, Dickinson And Company|Antimicrobial obturator for use with vascular access devices|
    US9675793B2|2014-04-23|2017-06-13|Becton, Dickinson And Company|Catheter tubing with extraluminal antimicrobial coating|
    US10376686B2|2014-04-23|2019-08-13|Becton, Dickinson And Company|Antimicrobial caps for medical connectors|
    US10232088B2|2014-07-08|2019-03-19|Becton, Dickinson And Company|Antimicrobial coating forming kink resistant feature on a vascular access device|
    US10232146B2|2014-09-05|2019-03-19|C. R. Bard, Inc.|Catheter insertion device including retractable needle|
    US10449331B2|2015-05-13|2019-10-22|B. Braun Melsungen Ag|Catheter devices with seals and related methods|
    CN113350614A|2015-05-15|2021-09-07|C·R·巴德股份有限公司|Catheter placement device including extendable needle safety feature|
    KR20180048694A|2015-08-18|2018-05-10|에스아이오2 메디컬 프로덕츠, 인크.|Packaging containers for medicines and other products with low oxygen transfer rates|
    ES2805302T3|2015-08-18|2021-02-11|Braun Melsungen Ag|Catheter Devices with Valves and Related Methods|
    US10478546B2|2015-09-15|2019-11-19|Surmodics, Inc.|Hemodialysis catheter sleeve|
    US10549072B2|2015-10-28|2020-02-04|Becton, Dickinson And Company|Integrated catheter with independent fluid paths|
    US10525237B2|2015-10-28|2020-01-07|Becton, Dickinson And Company|Ergonomic IV systems and methods|
    US10744305B2|2015-10-28|2020-08-18|Becton, Dickinson And Company|Ergonomic IV systems and methods|
    US10357636B2|2015-10-28|2019-07-23|Becton, Dickinson And Company|IV access device having an angled paddle grip|
    US10814106B2|2015-10-28|2020-10-27|Becton, Dickinson And Company|Soft push tabs for catheter adapter|
    US10493244B2|2015-10-28|2019-12-03|Becton, Dickinson And Company|Extension tubing strain relief|
    US10639455B2|2015-10-28|2020-05-05|Becton, Dickinson And Company|Closed IV access device with paddle grip needle hub and flash chamber|
    US10245416B2|2015-10-28|2019-04-02|Becton, Dickinson And Company|Intravenous catheter device with integrated extension tube|
    CN108367097A|2015-12-19|2018-08-03|心脏起搏器股份公司|Biologically inert coating for implantable medical device|
    WO2017143176A1|2016-02-18|2017-08-24|Smiths Medical Asd, Inc.|Closed system catheter|
    US10918835B2|2016-03-31|2021-02-16|Surmodics, Inc.|Delivery system for active agent coated balloon|
    US10032552B2|2016-08-30|2018-07-24|Becton, Dickinson And Company|Cover for tissue penetrating device with integrated magnets and magnetic shielding|
    US10493262B2|2016-09-12|2019-12-03|C. R. Bard, Inc.|Blood control for a catheter insertion device|
    US10238852B2|2016-10-05|2019-03-26|Becton, Dickinson And Company|Septum housing|
    USD844781S1|2016-10-05|2019-04-02|Becton, Dickinson And Company|Needle hub|
    USD837368S1|2016-10-05|2019-01-01|Becton, Dickinson And Company|Catheter adapter grip|
    USD819802S1|2016-10-05|2018-06-05|Becton, Dickinson And Company|Catheter adapter|
    USD835262S1|2016-10-05|2018-12-04|Becton, Dickinson And Company|Intravenous catheter assembly|
    USD808013S1|2016-10-27|2018-01-16|Smiths Medical Asd, Inc.|Catheter|
    JP6889820B2|2017-07-21|2021-06-18|株式会社トップ|Indwelling needle assembly|
    US10406326B2|2017-08-31|2019-09-10|I-V Access Technology, Inc.|Methods and devices for vascular access|
    US10994101B2|2018-03-02|2021-05-04|Becton, Dickinson And Company|Catheter assembly with high viscosity lubricant and related methods|
    USD921884S1|2018-07-27|2021-06-08|Bard Access Systems, Inc.|Catheter insertion device|
    US20210138202A1|2019-11-11|2021-05-13|Becton, Dickinson And Company|Catheter systems and methods for flashback visualization at various blood pressures|
    法律状态:
    2018-12-18| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2019-10-01| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|
    2020-07-14| B06A| Patent application procedure suspended [chapter 6.1 patent gazette]|
    2020-12-01| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|
    2021-02-17| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/02/2012, OBSERVADAS AS CONDICOES LEGAIS. |
    优先权:
    申请号 | 申请日 | 专利标题
    US13/042,154|US8679063B2|2009-02-11|2011-03-07|Systems and methods for providing a catheter assembly|
    US13/042,154|2011-03-07|
    PCT/US2012/025072|WO2012121843A1|2011-03-07|2012-02-14|Systems and methods for providing a catheter assembly|
    [返回顶部]